Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
22.4
Year-on-year change in revenue (%)Wording
Conditional
How definitive the wording is.Results for this period
Third quarter1 April 2025 to 31 December 2025ConsolidatedJapanese GAAPNet Sales7,975¥ millionYear on year +22.4%Progress 72.5%
Operating profit193¥ millionYear on year -42.4%Progress 31.6%
Ordinary income167¥ millionYear on year -29.7%Progress 29.8%
Net income attributable to owners of the parent13¥ millionYear on year -91.5%Progress 4.1%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share2円70銭
Financial position at period-end
Total assets10,830¥ million
of which net assets 3,500 ¥ millionEquity ratio 30.9%vs. prior year-end -2.9pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueMedical Business ¥2,088,487 thousand (YoY +368.3%), Platform Business ¥2,503,873 thousand (YoY -3.7%), Broadband business ¥2,707,481 thousand (YoY -3.4%), SaaS and DX Business ¥678,628 thousand (YoY +1.5%)
Segment profitMedical Business ¥-156,215 thousand, Platform Business ¥331,841 thousand (YoY -19.9%), Broadband business ¥403,237 thousand (YoY -6.6%), SaaS and DX Business ¥-75,942 thousand
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥11,000 million (YoY +21.0%)
Operating profit¥610 million (YoY +30.9%)
Ordinary income¥560 million (YoY +57.8%)
Net income¥320 million (YoY +73.8%)
Annual Dividend Forecast¥30 → ¥31.5（+5.0%）
Factors Behind Changes in Business Performance
メディカル事業では診療科目の拡大により大幅な増収となった一方、プラットフォーム事業では広告単価の下落が売上高及び営業利益に悪影響を及ぼした。ブロードバンド事業では10ギガ光回線の課金会員数が増加したが、ISP既存サービスの課金会員数は伸び悩み、SaaS・DX事業ではDXサービスが減収したもののSaaSサービスが成長した。
Disclosure regarding the going concern assumption
None
Change in accounting policy
基準改正に伴う変更 Noneそれ以外の変更 None見積りの変更 None修正再表示 None
Changes in the scope of consolidationNew 0 / Excluded 1 / Excluded Company Name ㈱NAPBIZ
Material subsequent eventsNo applicable matters
Impairment lossNone
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of property, plant and equipment ¥12,920 thousand / Extraordinary loss Head Office Relocation Costs ¥68,690 thousand, Business Exit Losses ¥33,150 thousand, Other ¥10,283 thousand
Depreciation and amortization¥140,059 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End4,873,830
Treasury Shares at Period-End74,000
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025 to 31 December 2025 |
| Net Sales | ¥7,975 million (YoY +22.4%) |
| Operating profit | ¥193 million (YoY -42.4%) |
| Ordinary income | ¥167 million (YoY -29.7%) |
| Profit attributable to owners of the parent | ¥13 million (YoY -91.5%) |
| Net income per share | 2円70銭 |
| Equity ratio | End of the current fiscal period 30.9 / End of previous period 33.8 |
| Total assets | ¥10,830 million |
| Net assets | ¥3,500 million |
| Full-year earnings forecast | Net Sales ¥11,000 million (YoY +21.0%) / Operating profit ¥610 million (YoY +30.9%) / Ordinary income ¥560 million (YoY +57.8%) / Net income ¥320 million (YoY +73.8%) |
| Annual Dividend Forecast | ¥30 → ¥31.5（+5.0%） |
| Segment revenue | Medical Business ¥2,088,487 thousand (YoY +368.3%), Platform Business ¥2,503,873 thousand (YoY -3.7%), Broadband business ¥2,707,481 thousand (YoY -3.4%), SaaS and DX Business ¥678,628 thousand (YoY +1.5%) |
| Segment profit | Medical Business ¥-156,215 thousand, Platform Business ¥331,841 thousand (YoY -19.9%), Broadband business ¥403,237 thousand (YoY -6.6%), SaaS and DX Business ¥-75,942 thousand |
| Depreciation and amortization | ¥140,059 thousand |
| Impairment loss | None |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of property, plant and equipment ¥12,920 thousand / Extraordinary loss Head Office Relocation Costs ¥68,690 thousand, Business Exit Losses ¥33,150 thousand, Other ¥10,283 thousand |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | New 0 / Excluded 1 / Excluded Company Name ㈱NAPBIZ |
| Material subsequent events | No applicable matters |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 4,873,830 |
| Treasury Shares at Period-End | 74,000 |
| Factors Behind Changes in Business Performance | メディカル事業では診療科目の拡大により大幅な増収となった一方、プラットフォーム事業では広告単価の下落が売上高及び営業利益に悪影響を及ぼした。ブロードバンド事業では10ギガ光回線の課金会員数が増加したが、ISP既存サービスの課金会員数は伸び悩み、SaaS・DX事業ではDXサービスが減収したもののSaaSサービスが成長した。 |
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.メディカル事業では診療科目が拡大した一方、プラットフォーム事業では広告単価が下落し、本社移転費用等を特別損失に計上したため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.